Lu Jun - Lotus Pharmaceuticals Director
| LTUS Stock | USD 0.01 0 28.57% |
Director
Mr. Jun Lu is Director of Lotus Pharmaceuticals, Inc. He was the head of research and development for Lotus Pharmaceuticals since 2006 and previously, from 2001 to 2003, worked at Beijing DoubleCrane Pharmaceutical Co., Ltd. Mr. Lu holds both a Master and a Bachelor degree in pharmacy from ShenYang Pharmaceutical University. His research focuses on various new pharmaceutical dosage forms, especially in osmotic pumpcontrolled release. Mr. Lu has published six papers in wellknown peerreviewed journals and filed four patents, two of which have been granted. Mr. Lus experience as head of research and development at the Company led to the conclusion he should serve on the Companys board of directors given the Companys business and structure. since 2010.
| Age | 30 |
| Tenure | 14 years |
| Phone | 615 310 2688 |
| Web | https://lotuspharmaceuticalsusa.com |
Lotus Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0456 % which means that it generated a profit of $0.0456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0182 %, meaning that it created $0.0182 on every $100 dollars invested by stockholders. Lotus Pharmaceuticals' management efficiency ratios could be used to measure how well Lotus Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | DIRECTOR Age | ||
| Khalil Barrage | Protagenic Therapeutics | 50 | |
| Brian Corvese | Protagenic Therapeutics | N/A | |
| Robert Stein | Protagenic Therapeutics | 65 | |
| Gregory Ekizian | Protagenic Therapeutics | 51 | |
| Joshua Silverman | Protagenic Therapeutics | 47 | |
Management Performance
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0456 |
Lotus Pharmaceuticals Leadership Team
Elected by the shareholders, the Lotus Pharmaceuticals' board of directors comprises two types of representatives: Lotus Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lotus. The board's role is to monitor Lotus Pharmaceuticals' management team and ensure that shareholders' interests are well served. Lotus Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lotus Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Li Zhaohui, Independent Director | ||
| Fan Lijun, Independent Director | ||
| Xing Shen, VP of Corporate Devel. | ||
| Yan Zeng, CFO and Principal Accounting Officer | ||
| Lu Jun, Director | ||
| Zhongyi Liu, Chairman of the Board and Presidentident, CEO | ||
| Zhong Liu, Chairman, Founder |
Lotus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Lotus Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0456 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 762.17 K | |||
| Shares Outstanding | 27.82 M | |||
| Price To Earning | 0.18 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 72.7 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lotus Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lotus Pharmaceuticals' short interest history, or implied volatility extrapolated from Lotus Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |